Answers are grounded in this paper and cite their sources.
Serum iron was estimated in 105 human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS) patients, 20 HIV-negative sexually transmitted disease (STD) patients and 25 voluntary healthy controls. Twenty-two clinical AIDS patients, 8 immunological AIDS patients, 2 HIV seropositive and 8 non-HIV STD controls had serum iron <60 mg/dl (Hb: <10 gm). Two clinical AIDS patients and two non-HIV STD controls showed serum iron level >161 µg/dl (Hb: 12-14 gm). Anemia was prevalent in AIDS cases, and the study of survival period may be unfolded in follow-up. Bone marrow biopsy could not be performed to identify the suppression of hemopoiesis in 4 patients, who showed >161 mg/dl of serum iron. Study of iron supplementation and long-term follow-up are necessary to unfold the risks and benefits of iron supplementation in HIV/AIDS patients.
No takes yet. Share an insight, caveat, or question.
Williams et al. (2007) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: